Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.06M | 8,209,725 | 3.32% | 96.68% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $12.56M | 51,456,077 | 10.48% | 12.05% | Net Buying | Net Buying | ||
| SKYE | SKYE BIOSCIENCE INC | $27.51M | 32,057,461 | 2.73% | 97.27% | Net Selling | |||
| ACET | ADICET BIO INC | $78.06M | 9,578,474 | 75.47% | 24.53% | Net Buying | Net Buying | ||
| NRXP | NRX PHARMACEUTICALS INC | $67.72M | 28,097,627 | 7.36% | 92.64% | ||||
| BTAI | BIOXCEL THERAPEUTICS INC | $39.15M | 21,869,491 | 1.18% | 98.82% | ||||
| PSTV | PLUS THERAPEUTICS INC | $76.96M | 137,429,055 | 3.79% | 17.39% | Net Buying | Net Buying | ||
| OSTX | OS THERAPIES INC | $50.71M | 35,214,352 | 4.44% | 18.78% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $18.97M | 24,292,833 | 3.72% | 59.15% | ||||
| RCKT | ROCKET PHARMACEUTICALS INC | $384.19M | 108,222,228 | 50.65% | 49.35% | Net Selling | Net Selling | ||
| SGMO | SANGAMO THERAPEUTICS INC | $148.06M | 336,494,489 | 18.60% | 9.54% | Net Selling | Net Selling | ||
| FEMY | FEMASYS INC | $33.98M | 58,479,824 | 6.42% | 4.05% | Net Buying | |||
| LSTA | LISATA THERAPEUTICS INC | $17.02M | 8,820,733 | 0.84% | 99.16% | Net Selling | |||
| TVRD | TVARDI THERAPEUTICS INC | $37.81M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| CODX | CO-DIAGNOSTICS INC | $11.65M | 2,029,753 | 34.61% | 65.39% | Net Selling | Net Selling | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $41.78M | 48,980,307 | 11.47% | 24.13% | Net Buying | |||
| IMUX | IMMUNIC INC | $76.62M | 120,284,724 | 35.49% | 13.20% | Net Buying | |||
| VERU | VERU INC | $36.76M | 16,050,320 | 6.39% | 93.61% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $15.93M | 2,152,444 | 23.87% | 76.13% | Net Buying | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $38.20M | 115,058,619 | 8.25% | 9.28% | ||||
| SLN | SILENCE THERAPEUTICS PLC | $279.82M | 141,701,848 | 13.91% | 0.09% | ||||
| KRRO | KORRO BIO INC | $75.34M | 9,417,295 | 25.66% | 74.34% | ||||
| SNTI | SENTI BIOSCIENCES INC | $29.71M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.08M | 4,230,448 | 1.01% | 69.58% | Net Buying | Net Buying | ||
| NAKA | KINDLY MD INC | $223.44M | 439,850,889 | 24.72% | 6.81% | Net Buying | |||
| PALI | PALISADE BIO INC | $312.91M | 149,003,210 | 0.08% | 5.55% | ||||
| ONCY | ONCOLYTICS BIOTECH INC | $100.01M | 103,635,734 | 2.72% | 1.90% | ||||
| IFRX | INFLARX NV | $77.23M | 67,747,130 | 27.40% | 0.00% | ||||
| AKTX | AKARI THERAPEUTICS PLC | $21.01M | 71,479,461,523 | 0.00% | 6.24% | Net Buying | Net Buying | ||
| ATYR | ATYR PHARMA INC | $73.10M | 97,986,634 | 63.19% | 15.70% | Net Buying | Net Buying | ||
| HUMA | HUMACYTE INC | $198.51M | 187,271,321 | 24.49% | 16.42% | Net Selling | |||
| CTSO | CYTOSORBENTS CORP | $41.83M | 62,804,305 | 26.01% | 45.21% | Net Buying | Net Buying | ||
| VNRX | VOLITIONRX LTD | $34.38M | 122,801,572 | 21.27% | 31.03% | Net Buying | Net Buying | ||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $16.49M | 11,454,512 | 13.23% | 0.00% | ||||
| CING | CINGULATE INC | $32.10M | 6,757,070 | 3.76% | 96.24% | ||||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $165.26M | 121,511,580 | 3.32% | 33.62% | Net Selling | Net Selling | ||
| MREO | MEREO BIOPHARMA GROUP PLC | $76.54M | 795,658,504 | 12.60% | 4.18% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $121.22M | 166,505,885 | 20.74% | 22.99% | Net Buying | Net Selling | ||
| MSAI | MULTISENSOR AI HOLDINGS INC | $19.86M | 52,537,883 | 28.70% | 66.36% | Net Selling | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.26M | 48,540,200 | 32.74% | 67.26% | Net Selling | Net Selling | ||
| ZSPC | ZSPACE INC | $16.15M | 29,050,067 | 1.28% | 98.72% | Net Selling | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $7.18M | 10,075,954 | 0.22% | 16.85% | Net Selling | Net Selling | ||
| MYO | MYOMO INC | $41.51M | 38,435,524 | 35.34% | 11.08% | Net Buying | Net Buying | ||
| CABA | CABALETTA BIO INC | $211.78M | 96,265,204 | 71.90% | 4.39% | ||||
| RZLT | REZOLUTE INC | $182.21M | 92,727,532 | 44.64% | 55.36% | Net Buying | Net Buying | ||
| IBRX | IMMUNITYBIO INC | $2.05B | 984,965,179 | 14.52% | 7.77% | Net Selling | Net Selling | ||
| BMEA | BIOMEA FUSION INC | $90.50M | 70,703,639 | 35.45% | 24.59% | Net Buying | Net Buying | ||
| HELP | CYBIN INC | $178.05M | 23,033,127 | 40.05% | 0.00% | ||||
| TCRX | TSCAN THERAPEUTICS INC | $59.02M | 56,747,993 | 60.97% | 30.00% | Net Buying | Net Buying | ||
| JSPR | JASPER THERAPEUTICS INC | $51.21M | 27,984,039 | 29.25% | 70.75% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.